Skip to content
Screener

Omeros OMER Gross Profit

Discontinued — last reported Q3 '21

Gross Profit at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$21.81M+2.9%
CTO
Citius Oncology, Inc.CTOR
$1.34M—

Other financials

Income statement

See full
Revenue$9.9M—
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$958.97M+245%
P/S10.7×—

Profitability

See full
Gross margin98.9%—
Operating margin-181.8%—
Net margin-136.6%—
FCF margin-121.6%—

Returns & leverage

See full
Return on equity86.6%—
Debt / equity0.3×-1.1×
Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

$30.0Mtotal revenue−$333.0Ktotal cost of revenue=$29.67M

The source filing: Omeros’s 10-Q, filed November 9, 2021. Open the filing →

Filed
Nov 9, 2021, 4:10 PM EST
Fiscal quarter
Q3 FY2021
Calendar quarter
Q3 2021
Accession
0001558370-21-015289

FAQ

What is Omeros's gross profit?
Omeros (OMER) reported gross profit of $29.67M in Q3 2021.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Omeros's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude